Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
International Journal of Obesity (2005)
|
December 12, 2012
A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations
I Naka, K Hikami, K Nakayama, et al.
Urologic Oncology
|
May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction
Yuki Kita, Katsuhiro Ito, Sohei Kanda, et al.
Oncotarget
|
June 15, 2018
Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma
Atsushi Shiozaki, Shoichiro Hikami, Daisuke Ichikawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2013
Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1)
Zhe Nie, Victoria Feher, Srinivasa Natala, et al.
Cancer Medicine
|
May 1, 2021
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
Katsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 21, 2021
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
Minoru Kato, Takashi Kobayashi, Yoshiyuki Matsui, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
International Journal of Obesity (2005)
|
December 12, 2012
A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations
I Naka, K Hikami, K Nakayama, et al.
Urologic Oncology
|
May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction
Yuki Kita, Katsuhiro Ito, Sohei Kanda, et al.
Oncotarget
|
June 15, 2018
Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma
Atsushi Shiozaki, Shoichiro Hikami, Daisuke Ichikawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2013
Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1)
Zhe Nie, Victoria Feher, Srinivasa Natala, et al.
Cancer Medicine
|
May 1, 2021
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
Katsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 21, 2021
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
Minoru Kato, Takashi Kobayashi, Yoshiyuki Matsui, et al.
Page
of 6